This conclusion is very significant because for the treatment of patients with IMF associated with obesity and detected IR (based on HOMA-IR models and Caro index), insulin sensitizers are often used, including metformin, the indications of which in children and adolescents are limited. This evidence concerns the gene INS and obesity disorder.